0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Comment & Response |

Clinical Decision Making in Patients With Thyroid Nodules

Jorge Luiz Gross, MD, PhD1; Caroline K. Kramer, MD, PhD2; Luciana Reck Remonti, MD1
[+] Author Affiliations
1Serviço de Endocrinologia do Hospital de Clínicas de Porto Alegre, Universidade Federal do Rio Grande do Sul, Porto Alegre-RS, Brazil
2Division of Endocrinology, University of Toronto and Leadership Sinai Centre for Diabetes, Mount Sinai Hospital, Toronto, Ontario, Canada
JAMA Intern Med. 2014;174(6):1005-1006. doi:10.1001/jamainternmed.2014.42.
Text Size: A A A
Published online

Extract

To the Editor In a recent issue of JAMA Internal Medicine, Smith-Bindman et al1 addressed the question of which ultrasound imaging characteristics are useful in identifying patients with thyroid nodules who are more likely to have thyroid cancer. This study adds important information for the proper clinical decision making in patients with thyroid nodules; however, some aspects need further clarification. First and foremost is the definition of noncancerous nodules, which was already addressed in the Invited Commentary.2 The definition adopted for benign nodules was based on the assumption that no cancer was identified, when in fact it is unknown how many of these patients underwent fine-needle aspiration or surgery. Indeed, the degree of uncertainty regarding this aspect is crucial and somewhat worrying because all analyses presented were based on this assumption. Second, the size of the nodule is another aspect that deserves further discussion. In this context, a receiver operating characteristic curve analysis of the size of nodules would have added value to identify possible thresholds of size associated with increased risk of harboring a thyroid cancer. This is clinically relevant because recent reports observed that approximately 19% to 30% of patients with thyroid microcarcinoma may present a more aggressive tumor behavior with regional and distant metastasis.3,4 Finally, it would be interesting to present the posttest probability of each ultrasound imaging characteristic by using the Fagan nomogram.5 By doing so, the unusual low pretest probability of thyroid cancer (1.6%) in this sample of patients with thyroid nodules would have been taken into consideration, providing better estimates of the clinical applicability of the studied ultrasonographic parameters.

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

June 1, 2014
Rebecca Smith-Bindman, MD
1Department of Radiology and Biomedical Imaging, University of California, San Francisco2Department of Epidemiology and Biostatistics, University of California, San Francisco3Department of Health Policy and Obstetrics, Gynecology and Reproductive Sciences, University of California, San Francisco4Radiology Outcomes Research Lab, University of California, San Francisco
JAMA Intern Med. 2014;174(6):1006. doi:10.1001/jamainternmed.2014.38.
CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

See Also...
Jobs
brightcove.createExperiences();